Ursamin Announces Formation of Advisory Board to Enhance Care Coordination

Group to Guide Platform for Streamlining Outpatient Care Coordination

FAYETTEVILLE, NY / ACCESSWIRE / April 2, 2024 / Ursamin, an emerging healthcare technology company dedicated to advancing the field of care coordination for patients with multiple chronic conditions (MCC), announced the formation of its Advisory Board.

The Advisory Board includes leaders in primary care, population health, care management and value-based care. The advisors will collaborate with the Ursamin leadership team to develop a platform tailored to the needs of family medicine and internal medicine practices, driving better care collaboration within primary care practices to manage patient populations, reduce costs and improve outcomes.

People living with MCC (PLWMCC) account for a disproportionate share of healthcare utilization and costs, 64% of all clinician visits, 70% of all inpatient stays, 83% of all prescriptions, 71% of all healthcare spending, and 93% of Medicare spending.[1]

The Agency for Healthcare Research and Quality (AHRQ) envisions a sustainable healthcare system that delivers high-value, coordinated, integrated patient-centered care, based in primary care, that will optimize individual and population health by preventing and effectively managing multiple chronic conditions.[2]

The advisors want to help change the trajectory. “Patients with multiple chronic conditions have a huge impact across the healthcare system, and care coordination has become an imperative,” said Shannon Aylesworth, CEO and Founder of Ursamin. “Our new advisors understand these forces firsthand and will provide invaluable perspectives to help us strengthen our platform and focus on areas that drive the most value for family medicine and internal medicine practices. We’re thrilled to have their guidance and support.”

Ursamin is committed to improving the lives of patients living with multiple chronic conditions by empowering primary care physicians and specialists with a care coordination platform that streamlines operational workflows – benefiting providers, caregivers and patients. The Advisory Board will play a pivotal role in ensuring Ursamin is at the forefront – delivering solutions that enable seamless collaboration and with a goal of achieving better patient outcomes.

About Ursamin

Ursamin is a care coordination platform designed to help providers more effectively manage patients living with multiple chronic illnesses. Our platform prioritizes improving data flow, enhancing patient engagement, and facilitating seamless collaboration among providers, patients, and caregivers. Learn more at ursamin.com.

For media inquiries or further information, please contact:

Lisa Ganier
lganier@ursamin.com

[1], [2] Advancing Patient-Centered Care for People Living With Multiple Chronic Conditions. Content last reviewed July 2023. Agency for Healthcare Research and Quality, Rockville, MD.
https://www.ahrq.gov/patient-safety/settings/long-term-care/resource/multichronic/mcc.html

SOURCE: Ursamin

View the original press release on accesswire.com

Staff

Recent Posts

Pre-JPM Investor Pulse Signals 2026 Capital Rotation Toward “AI That Ships,” Admin Cost Takeout, and Differentiated Metabolic Assets With Special-Situations Capital Back in Scope

Preliminary, directional read of planned 88-investor sample indicates heightened proof thresholds (unit economics, reimbursement, outcomes)…

10 hours ago

Best GLP-1 Weight Loss Shot (2026): Direct Meds Reviews Prescription Access Pathways as New GLP-1 Formats Expand

LegitScript-certified telehealth platform publishes consumer analysis as searches for GLP-1 weight loss information reach record…

13 hours ago

Nutri Derma Guard Skin Tag Remover Ingredients Investigated: 2026 Analysis Examines Formulation And Consumer Disclosures

Independent investigation examines castor oil, tea tree oil, and salicylic acid formulation claims in the…

13 hours ago

SleepZee Mouth Guard Legitimacy Examined: 2026 Consumer Analysis Investigates Anti-Snoring Device Claims and Company Transparency

Independent examination investigates SleepZee's moldable customization approach, medical-grade material claims, and manufacturer disclosure practices for…

13 hours ago